Overview
Melanoma cells are malignant transformations of melanocytes, the pigment-producing cells in the skin. These cells are central to melanoma, the most aggressive form of skin cancer, known for its high metastatic potential and resistance to treatment. Melanoma cells often retain melanin-producing capabilities, though amelanotic variants also exist. Their study is critical for advancing therapeutic strategies, particularly in targeted therapies and immunotherapies. Research on melanoma cells has revealed key genetic mutations, such as BRAF and NRAS, which drive uncontrolled proliferation. Cell lines derived from patient tumors are widely used in laboratories to model disease progression and test novel compounds. Understanding their behavior helps clinicians predict tumor aggressiveness and personalize treatment plans.
Key Features
Melanoma cells exhibit distinct morphological and molecular traits. They often display irregular nuclei, high mitotic activity, and cytoplasmic melanin granules (in pigmented types). At the molecular level, mutations in pathways like MAPK/ERK are common, making them targets for precision drugs such as BRAF inhibitors. Another hallmark is their adaptability to microenvironments, enabling metastasis to lymph nodes, lungs, and brain. Epithelial-to-mesenchymal transition (EMT) further enhances their invasive properties. Researchers use markers like S100, HMB-45, and Melan-A to identify these cells in diagnostic assays.
Application Areas
In oncology research, melanoma cells are indispensable for studying tumor biology, drug resistance, and metastasis mechanisms. They serve as models for preclinical testing of chemotherapies, immunotherapies (e.g., PD-1 inhibitors), and combination therapies. Clinically, these cells aid in diagnostic procedures like biopsies and liquid biopsies for circulating tumor DNA. Pharmaceutical companies leverage them to develop biomarker-based assays, accelerating drug discovery. Additionally, melanoma cell lines are used in academic settings to explore tumor-microenvironment interactions and immune evasion tactics.
Precautions
Handling melanoma cells requires adherence to biosafety protocols to prevent contamination or accidental exposure. BSL-2 containment is recommended, with personal protective equipment (PPE) including gloves and lab coats. Proper disposal of biohazardous waste is mandatory. Researchers must authenticate cell lines regularly to avoid cross-contamination or misidentification, which can compromise experimental results. Ethical guidelines apply when using patient-derived cells, ensuring informed consent and compliance with institutional review boards (IRBs).
B2B Procurement Guide
When sourcing melanoma cell lines for research, prioritize reputable suppliers like ATCC or DSMZ, which provide certified cell banks with detailed characterization data. Key selection criteria include mutation profiles (e.g., BRAF/NRAS status), growth requirements, and metastatic potential. For bulk procurement, negotiate licensing terms covering intellectual property and usage restrictions. Consider cryopreserved vials for long-term storage and request viability certificates. Collaborative projects may benefit from custom cell line development services to match specific research needs.
Related Manufacturers
- 主营：培养基、动物红细胞、原代细胞、人眼葡萄膜黑色瘤細胞、细胞系、Elisa试剂盒